BIOTECHNOLOGY INNOVATION ORGANIZATION: Form 990, tax year 2024

View the entire original 990 at ProPublica ↗

Organization: BIOTECHNOLOGY INNOVATION ORGANIZATION (EIN 52-1224577)
Tax period: 2024-01-01 to 2024-12-31
Filed: 2025-11-07
IRS object ID: 202543119349303399
Schema version: 2024v5.2
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule C
Schedule D
Schedule F
Schedule I
Schedule J
Schedule L
Schedule O

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2025-11-07T15:15:07-06:00	ReturnTs
Tax Period End	2024-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Field	Value	IRS element (for citing)
Preparer Firm EIN	410746749	PreparerFirmEIN

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	CLIFTONLARSONALLEN LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	TWO INTERNATIONAL PLACE 22ND FLOOR	AddressLine1Txt
City	BOSTON	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	02110	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2024-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	521224577	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	BIOTECHNOLOGY INNOVATION ORGANIZATION	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	BIOT	BusinessNameControlTxt
Phone	2029629200	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 NEW YORK AVE NW NO 1300	AddressLine1Txt
City	WASHINGTON	CityNm
State Abbreviation	DC	StateAbbreviationCd
ZIP	20005	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	STEPHEN JASKO	PersonNm
Person Title	CHIEF BUSN & FINANCIAL OFFICER	PersonTitleTxt
Phone	2029629200	PhoneNum
Signature	2025-11-05	SignatureDt
Discuss With Paid Preparer	Yes (1)	DiscussWithPaidPreparerInd

Field	Value	IRS element (for citing)
IRS Responsible Prty Info Curr	0	IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	LAURA J KENNEY	PreparerPersonNm
PTIN	P00202198	PTIN
Phone	6177170831	PhoneNum
Preparation	2025-11-05	PreparationDt

Field	Value	IRS element (for citing)
Tax	2024	TaxYr
Build TS	2025-03-06 01:10:19Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	JOHN CROWLEY	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 NEW YORK AVE NW NO 1300	AddressLine1Txt
City	WASHINGTON	CityNm
State Abbreviation	DC	StateAbbreviationCd
ZIP	20005	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$214,116,938	GrossReceiptsAmt
Group Return For Affiliates	0	GroupReturnForAffiliatesInd
Organization501c	Yes (X)	Organization501cInd
Website Address	WWW.BIO.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1981	FormationYr
Legal Domicile State	DC	LegalDomicileStateCd
Activity Or Mission	BIO IS THE WORLD'S LARGEST ADVOCACY ASSOCIATION REPRESENTING APPROXIMATELY 1,000 MEMBER COMPANIES, STATE BIOTECHNOLOGY GROUPS, ACADEMIC AND RESEARCH INSTITUTIONS, PATIENT GROUPS, AND RELATED ORGANIZATIONS ACROSS THE UNITED STATES AND IN 30+ COUNTRIES. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. BIO'S EFFORTS INCLUDE ADVOCACY AND POLICY EFFORTS FOCUSED ON THE INNOVATIVE HEALTH OF THE SECTOR ALONG WITH CONVENING EVENTS AND OFFERING OTHER MEMBER SERVICES.	ActivityOrMissionDesc
Voting Members Governing Body	86	VotingMembersGoverningBodyCnt
Voting Members Independent	85	VotingMembersIndependentCnt
Total Employee	180	TotalEmployeeCnt
Total Volunteers	113	TotalVolunteersCnt
Total Gross UBI	$40,500	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$0	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$0	PYContributionsGrantsAmt
CY Contributions Grants	$0	CYContributionsGrantsAmt
PY Program Service Revenue	$93,460,509	PYProgramServiceRevenueAmt
CY Program Service Revenue	$91,769,762	CYProgramServiceRevenueAmt
PY Investment Income	$2,221,609	PYInvestmentIncomeAmt
CY Investment Income	$9,375,263	CYInvestmentIncomeAmt
PY Other Revenue	$18,086,391	PYOtherRevenueAmt
CY Other Revenue	$16,603,683	CYOtherRevenueAmt
PY Total Revenue	$113,768,509	PYTotalRevenueAmt
CY Total Revenue	$117,748,708	CYTotalRevenueAmt
PY Grants And Similar Paid	$1,534,902	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$2,331,287	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$39,078,972	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$41,996,482	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$0	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$0	CYTotalFundraisingExpenseAmt
PY Other Expenses	$51,016,290	PYOtherExpensesAmt
CY Other Expenses	$55,683,017	CYOtherExpensesAmt
PY Total Expenses	$91,630,164	PYTotalExpensesAmt
CY Total Expenses	$100,010,786	CYTotalExpensesAmt
PY Revenues Less Expenses	$22,138,345	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$17,737,922	CYRevenuesLessExpensesAmt
Total Assets BOY	$156,639,347	TotalAssetsBOYAmt
Total Assets EOY	$170,089,094	TotalAssetsEOYAmt
Total Liabilities BOY	$79,279,320	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$76,918,293	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$77,360,027	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$93,170,801	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	THE BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) REPRESENTS APPROXIMATELY 1,000 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES.	MissionDesc
Significant New Program Srvc	0	SignificantNewProgramSrvcInd
Significant Change	0	SignificantChangeInd
Desc	ADVOCACY: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE THREE SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS FOR THE YEAR ARE LISTED BELOW: - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT PROACTIVELY ADVANCING THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION ADVOCACY ACCOMPLISHMENTS: - PROMOTED HEALTHCARE POLICIES THAT RECOGNIZE BOTH THE PROMISE AND VALUE OF INNOVATION.- ADVOCATED FOR A SAFE AND PREDICTABLE REGULATORY ENVIRONMENT FOR VALUE-BASED PAYMENT ARRANGEMENTS FOR DRUGS AND BIOLOGICS.- ENHANCED AND PROTECTED PATIENT ACCESS TO INNOVATIVE THERAPIES AND PROMOTED THE NEED FOR GREATER NONDISCRIMINATION ENFORCEMENT AGAINST INSURANCE BENEFIT DESIGNS.- ADVOCATED FOR BIOSIMILARS POLICIES THAT PROTECT PATIENT SAFETY, PROMOTE BIOMEDICAL INNOVATION, AND ADVANCE THE SCIENCE-BASED REVIEW AND APPROVAL OF BIOSIMILARS AND INTERCHANGEABLE BIOLOGICAL PRODUCTS.- PROMOTED THE VALUE OF U.S. GOVERNMENT INVESTMENTS IN PROGRAMS THAT IMPROVE ACCESS TO IMMUNIZATIONS AND FOSTER VACCINE INNOVATION, STRENGTHENED OUR ABILITY TO RESPOND TO BIOTERROR THREATS OR EMERGING INFECTIOUS DISEASES, AND ENCOURAGED DEVELOPMENT OF NEW PRODUCTS TO FIGHT ANTIMICROBIAL RESISTANCE (AMR).- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION AND GLOBAL PUBLIC HEALTH PREPAREDNESS.- ADVOCATED FOR THE MODERNIZATION OF THE CLINICAL DEVELOPMENT PARADIGM.THE EMERGING COMPANIES SECTION ADVOCACY ACCOMPLISHMENTS: - ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY.- ADVOCATED FOR FISCAL POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES AND INVESTMENT IN GROUNDBREAKING R&D; ENHANCED THE VOICE OF PRE-REVENUE, R&D-INTENSIVE BUSINESSES- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES.THE AGRICULTURE & ENVIRONMENT SECTION ADVOCACY ACCOMPLISHMENTS:BIO'S AGRICULTURE & ENVIRONMENT (OR AG & ENVIRONMENT) SECTION FOCUSES ON ISSUES RELATED TO THE ORGANIZATION'S PRIOR FOOD & AGRICULTURE AND INDUSTRIAL & ENVIRONMENT SECTIONS. THESE INCLUDE:- ADVOCATING ON INITIATIVES THAT STRENGTHEN THE BIOECONOMY; AND- MEETING SHARED GOALS RELATED TO SOCIETAL CHALLENGES SUCH AS FOOD SECURITY, NATIONAL SECURITY AND CLIMATE CHANGE.THE AG & ENVIRONMENT SECTION ADVOCATES AND COORDINATES DIRECTLY WITH GOVERNMENT AND INDUSTRY STAKEHOLDERS TO INCREASE THE UNDERSTANDING AND ACCEPTANCE OF BIOTECH INNOVATION, WHILE ALSO IMPROVING THE REGULATORY AND APPROVAL PROCESSES. THIS SECTION PROMOTES APPROPRIATE INITIATIVES THAT SUPPORT INNOVATION, MARKET ACCESS, AND MARKET ACCEPTANCE.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Desc	SERVICES: BIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING ADVOCACY ACCOMPLISHMENTS LISTED BELOW:- SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT PROACTIVELY ADVANCING THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- BROUGHT TOGETHER INDUSTRY STAKEHOLDERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINESS DEVELOPMENT EXECUTIVES.THE BIO INTERNATIONAL CONVENTION ATTRACTS THE MOST INFLUENTIAL BIOTECH AND PHARMA ATTENDEES FROM 69 COUNTRIES AND 50 U.S. STATES, AS WELL AS THE DISTRICT OF COLUMBIA AND PUERTO RICO AND OFFERS PROFESSIONAL AND BUSINESS DEVELOPMENT OPPORTUNITIES. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES.THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION, THE BIO BUSINESS FORUM, AND NETWORKING EVENTS. THESE ELEMENTS PROVIDE AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO LEARN ABOUT RECENT SCIENTIFIC AND POLICY DEVELOPMENTS, AND SCHEDULE ONE-ON-ONE MEETINGS TO DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. THE BIO BUSINESS FORUM AT THE CONVENTION HOSTS TENS OF THOUSANDS OF PARTNERING MEETINGS AMONG A FEW THOUSAND COMPANIES, ALONG WITH A COUPLE HUNDRED COMPANY PRESENTATIONS. THE CONVENTION HOSTS HUNDREDS OF SPEAKERS, AND OVER A THOUSAND EXHIBITIONS WITH INTERNATIONAL, REGIONAL AND STATE PAVILIONS (AND A NUMBER OF PRODUCT FOCUS ZONES).BEYOND THE CONVENTION, BIO HOSTS OR CO-HOSTS A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS.	Desc

Field	Value	IRS element (for citing)
Described In Section501c3	0	DescribedInSection501c3Ind
Schedule B Required	0	ScheduleBRequiredInd
Political Campaign Acty	0	PoliticalCampaignActyInd
Subject To Proxy Tax	Yes (1)	SubjectToProxyTaxInd
Donor Advised Fund	0	DonorAdvisedFundInd
Conservation Easements	0	ConservationEasementsInd
Collections Of Art	0	CollectionsOfArtInd
Credit Counseling	0	CreditCounselingInd
Donor Rstr Or Quasi Endowments	0	DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment	Yes (1)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	0	ReportInvestmentsOtherSecInd
Report Program Related Invst	0	ReportProgramRelatedInvstInd
Report Other Assets	Yes (1)	ReportOtherAssetsInd
Report Other Liabilities	Yes (1)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (1)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	Yes (1)	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	0	ConsolidatedAuditFinclStmtInd
School Operating	0	SchoolOperatingInd
Foreign Office	0	ForeignOfficeInd
Foreign Activities	Yes (1)	ForeignActivitiesInd
More Than5000 K To Org	Yes (1)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	0	MoreThan5000KToIndividualsInd
Professional Fundraising	0	ProfessionalFundraisingInd
Fundraising Activities	0	FundraisingActivitiesInd
Gaming Activities	0	GamingActivitiesInd
Operate Hospital	0	OperateHospitalInd
Grants To Organizations	Yes (1)	GrantsToOrganizationsInd
Grants To Individuals	0	GrantsToIndividualsInd
Schedule J Required	Yes (1)	ScheduleJRequiredInd
Tax Exempt Bonds	0	TaxExemptBondsInd
Loan Outstanding	0	LoanOutstandingInd
Grant To Related Person	0	GrantToRelatedPersonInd
Business Rln With Org Mem	Yes (1)	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	0	BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent	0	BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri	0	DeductibleNonCashContriInd
Deductible Art Contribution	0	DeductibleArtContributionInd
Terminate Operations	0	TerminateOperationsInd
Partial Liquidation	0	PartialLiquidationInd
Disregarded Entity	0	DisregardedEntityInd
Related Entity	0	RelatedEntityInd
Related Organization Ctrl Ent	0	RelatedOrganizationCtrlEntInd
Activities Conducted Prtshp	0	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (1)	ScheduleORequiredInd
IRP Document	161	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (1)	BackupWthldComplianceInd
Employee	180	EmployeeCnt
Employment Tax Returns Filed	Yes (1)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (1)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (1)	Form990TFiledInd
Foreign Financial Account	0	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTransInd
Taxable Party Notification	0	TaxablePartyNotificationInd
Nondeductible Contributions	0	NondeductibleContributionsInd
Indoor Tanning Services	0	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	Yes (1)	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	0	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	86	GoverningBodyVotingMembersCnt
Independent Voting Member	85	IndependentVotingMemberCnt
Family Or Business Rln	0	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	0	DelegationOfMgmtDutiesInd
Change To Org Documents	0	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	0	MaterialDiversionOrMisuseInd
Members Or Stockholders	Yes (1)	MembersOrStockholdersInd
Election Of Board Members	Yes (1)	ElectionOfBoardMembersInd
Decisions Subject To Approva	0	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (1)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (1)	MinutesOfCommitteesInd
Officer Mailing Address	0	OfficerMailingAddressInd
Local Chapters	0	LocalChaptersInd
Form990 Provided To Gvrn Body	0	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (1)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (1)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (1)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (1)	WhistleblowerPolicyInd
Document Retention Policy	Yes (1)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (1)	CompensationProcessCEOInd
Compensation Process Other	Yes (1)	CompensationProcessOtherInd
Investment In Joint Venture	0	InvestmentInJointVentureInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	STEPHEN JASKO CHIEF BUSINESS FIN	PersonNm
Phone	2029629200	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 NEW YORK AVE NW STE 1300	AddressLine1Txt
City	WASHINGTON	CityNm
State Abbreviation	DC	StateAbbreviationCd
ZIP	20005	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (118 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Highest Compensated EmployeeHighestCompensatedEmployeeInd	Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
JOHN F CROWLEY
PRESIDENT AND CEO	40.00	Yes (X)	Yes (X)	$2,747,033	$0	$365,352
FRITZ BITTENBENDER
BOARD & HEALTH SECTION VICE CHAIR	2.00	Yes (X)	Yes (X)	$0	$0	$0
GRACE E COLON
EMERGING COMPANIES SECTION V CHAIR	2.00	Yes (X)	Yes (X)	$0	$0	$0
PAUL J HASTINGS
IMMEDIATE PAST CHAIR	2.00	Yes (X)	Yes (X)	$0	$0	$0
ELIZABETH LEWIS UNTIL 32024
ASSOCIATE VICE CHAIR & SECRETARY	2.00	Yes (X)	Yes (X)	$0	$0	$0
TED W LOVE
BOARD & HEALTH SECTION CHAIR	2.00	Yes (X)	Yes (X)	$0	$0	$0
WILLIAM J NEWELL
ASSOCIATE VICE CHAIR & SECRETARY	2.00	Yes (X)	Yes (X)	$0	$0	$0
ANNA RATH UNTIL 32024
AGRICULTURE & ENV SECTION CHAIR	2.00	Yes (X)	Yes (X)	$0	$0	$0
DUANE J SIMPSON
AGRICULTURE & ENV SECTION VICE CHAIR	2.00	Yes (X)	Yes (X)	$0	$0	$0
ERIKA SMITH
EMERGING COMPANIES SECTION CHAIR	2.00	Yes (X)	Yes (X)	$0	$0	$0
TAD SONSTEGARD
AGRICULTURE & ENV SECTION VICE CHAIR	2.00	Yes (X)	Yes (X)	$0	$0	$0
BRADFORD A ZAKES
TREASURER	2.00	Yes (X)	Yes (X)	$0	$0	$0
ANGELA CARISA AILLONI
DIRECTOR (UNTIL DECEMBER 2024)	2.00	Yes (X)		$0	$0	$0
STEVE ALBERS
DIRECTOR	2.00	Yes (X)		$0	$0	$0
STUART A ARBUCKLE
DIRECTOR	2.00	Yes (X)		$0	$0	$0
MARTIN BABLER
DIRECTOR	2.00	Yes (X)		$0	$0	$0
MARIANNE DE BACKER
DIRECTOR	2.00	Yes (X)		$0	$0	$0
BRAD BAILEY
DIRECTOR	2.00	Yes (X)		$0	$0	$0
JACOB BECRAFT
DIRECTOR	2.00	Yes (X)		$0	$0	$0
SULAGNA BHATTACHARYA
DIRECTOR	2.00	Yes (X)		$0	$0	$0
ROBERT BLUM
DIRECTOR	2.00	Yes (X)		$0	$0	$0
CARRIE L BOURDOW
DIRECTOR (UNTIL DECEMBER 2024)	2.00	Yes (X)		$0	$0	$0
CARINE BOUSTANY
DIRECTOR	2.00	Yes (X)		$0	$0	$0
DAVID BOYER
DIRECTOR	2.00	Yes (X)		$0	$0	$0
STEPHEN BRADY
DIRECTOR	2.00	Yes (X)		$0	$0	$0
CHRISTINE BRENNAN
DIRECTOR	2.00	Yes (X)		$0	$0	$0
VICTOR BULTO
DIRECTOR	2.00	Yes (X)		$0	$0	$0
JOHN BUTLER
DIRECTOR	2.00	Yes (X)		$0	$0	$0
GIACOMO CHIESI
DIRECTOR	2.00	Yes (X)		$0	$0	$0
JEFFREY L CLELAND
DIRECTOR	2.00	Yes (X)		$0	$0	$0
RON COHEN
DIRECTOR (UNTIL JUNE 2024)	2.00	Yes (X)		$0	$0	$0
BRUCE C COZADD
DIRECTOR	2.00	Yes (X)		$0	$0	$0
MIKE DIAL
DIRECTOR	2.00	Yes (X)		$0	$0	$0
ERIC M DUBE
DIRECTOR	2.00	Yes (X)		$0	$0	$0
MARC DUNOYER
DIRECTOR	2.00	Yes (X)		$0	$0	$0
MARK ENYEDY
DIRECTOR (UNTIL MAY 2024)	2.00	Yes (X)		$0	$0	$0
DAVID ESPOSITO
DIRECTOR	2.00	Yes (X)		$0	$0	$0
BARRY P FLANNELLY
DIRECTOR	2.00	Yes (X)		$0	$0	$0
ALEXANDRIA FORBES
DIRECTOR	2.00	Yes (X)		$0	$0	$0
KAYE FOSTER
DIRECTOR (UNTIL MAY 2024)	2.00	Yes (X)		$0	$0	$0
CEDRIC FRANCOIS
DIRECTOR (UNTIL SEPTEMBER 2024)	2.00	Yes (X)		$0	$0	$0
CARI GALLMAN
DIRECTOR	2.00	Yes (X)		$0	$0	$0
KYLE GANO
DIRECTOR (UNTIL OCTOBER 2024)	2.00	Yes (X)		$0	$0	$0
DEBORAH GLASSER
DIRECTOR	2.00	Yes (X)		$0	$0	$0
JOHN GLASSPOOL
DIRECTOR	2.00	Yes (X)		$0	$0	$0
JENNIFER GOOD
DIRECTOR	2.00	Yes (X)		$0	$0	$0
KEVIN C GORMAN
DIRECTOR (UNTIL JUNE 2024)	2.00	Yes (X)		$0	$0	$0
YVONNE GREENSTREET
DIRECTOR	2.00	Yes (X)		$0	$0	$0
SEBASTIAN GUTH
DIRECTOR	2.00	Yes (X)		$0	$0	$0
KARIS GUTTER
DIRECTOR	2.00	Yes (X)		$0	$0	$0
ALEXANDER HARDY
DIRECTOR (UNTIL OCTOBER 2024)	2.00	Yes (X)		$0	$0	$0
STEVEN HARR
DIRECTOR	2.00	Yes (X)		$0	$0	$0
RACHEL HAURWITZ
DIRECTOR	2.00	Yes (X)		$0	$0	$0
KATE HAVILAND
DIRECTOR	2.00	Yes (X)		$0	$0	$0
DAVID HIRSCHI
DIRECTOR	2.00	Yes (X)		$0	$0	$0
JENNIFER HOLMGREN
DIRECTOR	2.00	Yes (X)		$0	$0	$0
CRISTIN HUBBARD
DIRECTOR	2.00	Yes (X)		$0	$0	$0
MIKE HUCKMAN
DIRECTOR	2.00	Yes (X)		$0	$0	$0
ELIZABETH JEFFORDS
DIRECTOR	2.00	Yes (X)		$0	$0	$0
SABRINA JOHNSON
DIRECTOR	2.00	Yes (X)		$0	$0	$0
PATRIK JONSSON
DIRECTOR	2.00	Yes (X)		$0	$0	$0
DAVID KETTNER
DIRECTOR	2.00	Yes (X)		$0	$0	$0
NINA KJELLSON
DIRECTOR	2.00	Yes (X)		$0	$0	$0
SCOTT KOENIG
DIRECTOR	2.00	Yes (X)		$0	$0	$0
NEIL KUMAR
DIRECTOR	2.00	Yes (X)		$0	$0	$0
JOSEPH J LAROSA
DIRECTOR	2.00	Yes (X)		$0	$0	$0
CHRIS LEIBMAN
DIRECTOR	2.00	Yes (X)		$0	$0	$0
JEREMY M LEVIN
DIRECTOR	2.00	Yes (X)		$0	$0	$0
SANDY MACRAE
DIRECTOR	2.00	Yes (X)		$0	$0	$0
GAIL MADERIS
DIRECTOR (UNTIL SEPTEMBER 2024)	2.00	Yes (X)		$0	$0	$0
ANTHONY MANCINI
DIRECTOR (UNTIL OCTOBER 2024)	2.00	Yes (X)		$0	$0	$0
MAYA MARTINEZ-DAVIS
DIRECTOR (UNTIL DECEMBER 2024)	2.00	Yes (X)		$0	$0	$0
SHARON MATES
DIRECTOR	2.00	Yes (X)		$0	$0	$0
THOMAS P MATHERS
DIRECTOR	2.00	Yes (X)		$0	$0	$0
REENIE MCCARTHY
DIRECTOR	2.00	Yes (X)		$0	$0	$0
SHEILA ANN MIKHAIL
DIRECTOR	2.00	Yes (X)		$0	$0	$0
FREDERICK MOORE
DIRECTOR	2.00	Yes (X)		$0	$0	$0
ROCCO MORELLI
DIRECTOR (UNTIL MARCH 2024)	2.00	Yes (X)		$0	$0	$0
MICHAEL M MORRISSEY
DIRECTOR	2.00	Yes (X)		$0	$0	$0
AMIR NASHAT
DIRECTOR (UNTIL JUNE 2024)	2.00	Yes (X)		$0	$0	$0
SONIA NATH
DIRECTOR	2.00	Yes (X)		$0	$0	$0
ANDREW OBENSHAIN
DIRECTOR	2.00	Yes (X)		$0	$0	$0
JANNIE OOSTHUIZEN
DIRECTOR	2.00	Yes (X)		$0	$0	$0
CATHERINE OWEN
DIRECTOR (UNTIL JANUARY 2024)	2.00	Yes (X)		$0	$0	$0
JULIA OWENS
DIRECTOR	2.00	Yes (X)		$0	$0	$0
JOHN V OYLER
DIRECTOR (UNTIL JUNE 2024)	2.00	Yes (X)		$0	$0	$0
CYNTHIA PERETTIE
DIRECTOR	2.00	Yes (X)		$0	$0	$0
RICHARD POPS
DIRECTOR	2.00	Yes (X)		$0	$0	$0
MARK PRUZANSKI
DIRECTOR	2.00	Yes (X)		$0	$0	$0
SOFIE QIAO
DIRECTOR (UNTIL MAY 2024)	2.00	Yes (X)		$0	$0	$0
MIKE G RAAB
DIRECTOR	2.00	Yes (X)		$0	$0	$0
MAGI RICHANI
DIRECTOR	2.00	Yes (X)		$0	$0	$0
MICHAEL J RUGGIERO
DIRECTOR	2.00	Yes (X)		$0	$0	$0
JAMES SAPIRSTEIN
DIRECTOR	2.00	Yes (X)		$0	$0	$0
CHRISTOPHE SCHILLING
DIRECTOR (UNTIL FEBRUARY 2024)	2.00	Yes (X)		$0	$0	$0
MICHAEL SCHOEN
DIRECTOR	2.00	Yes (X)		$0	$0	$0
HAROUT SEMERJIAN
DIRECTOR	2.00	Yes (X)		$0	$0	$0
NANCY SIMONIAN
DIRECTOR (UNTIL FEBRUARY 2024)	2.00	Yes (X)		$0	$0	$0
EDDIE J SULLIVAN
DIRECTOR	2.00	Yes (X)		$0	$0	$0
IAN THOMPSON
DIRECTOR (UNTIL OCTOBER 2024)	2.00	Yes (X)		$0	$0	$0
NOLAN TOWNSEND
DIRECTOR	2.00	Yes (X)		$0	$0	$0
LINDA TROLINDER
DIRECTOR (UNTIL JANUARY 2024)	2.00	Yes (X)		$0	$0	$0
NEIL K WARMA
DIRECTOR	2.00	Yes (X)		$0	$0	$0
FRANK WATANABE
DIRECTOR	2.00	Yes (X)		$0	$0	$0
SCOTT WHITE
DIRECTOR	2.00	Yes (X)		$0	$0	$0
LESLIE WILLIAMS
DIRECTOR	2.00	Yes (X)		$0	$0	$0
RICK E WINNINGHAM
DIRECTOR	2.00	Yes (X)		$0	$0	$0
SYLVIA WULF
DIRECTOR	2.00	Yes (X)		$0	$0	$0
TATSUYUKI YASUNO
DIRECTOR	2.00	Yes (X)		$0	$0	$0
DAPHNE ZOHAR
DIRECTOR	2.00	Yes (X)		$0	$0	$0
STEPHEN JASKO
CHIEF BUSINESS AND FINANCIAL OFFICER	40.00		Yes (X)	$808,510	$0	$86,616
RACHEL K KING
INTERIM PRESIDENT AND CEO	40.00		Yes (X)	$1,658,415	$0	$17,084
RICHARD MASTERS
CHIEF PUBLIC AFFAIRS & MARKETING OFF	40.00			$744,710	$0	$26,368	Yes (X)
LETONIA D FYKES
CHIEF EVENTS & INDUSTRY PROGRAMS OFFICER	40.00			$596,087	$0	$72,996	Yes (X)
ELIZABETH CARTIER ESHAM
CHIEF SCIENCE OFFICER	40.00			$1,012,398	$0	$18,928	Yes (X)
PETER MCHUGH
CHIEF LEGAL OFFICER	40.00			$688,807	$0	$90,259	Yes (X)
JOHN MURPHY
CHIEF POLICY OFFICER	40.00			$567,043	$0	$27,095	Yes (X)
MICHELLE MCMURRY-HEATH
FORMER PRESIDENT AND CEO	40.00			$264,130	$0	$0		Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$9,087,133	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$704,698	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	111	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	Yes (1)	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (1)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	0	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
THE SAMANTHA SAULT AGENCY LLC
2039 NEW HAMPSHIRE AVE NW SUITE 10	WASHINGTON	DC	20009	BESPOKE EDITORIAL CONTENT SERVICES	$596,393
NARRATIVE STRATEGIES
1400 L ST NW SUITE 500	WASHINGTON	DC	20005	STRATEGIC COMMUNICATIONS SERVICES	$492,650
KEYBRIDGE COMMUNICATIONS LLC
1722-A WISCONSIN AVE NW SUITE 21	WASHINGTON	DC	20007	PUBLIC RELATIONS AND ISSUE ADVOCACY	$240,000
ARENT FOX SCHIFF LLP
1717 K ST NW	WASHINGTON	DC	20006	LEGISLATIVE AND REGULATORY COUNSELING	$222,523
HEALTH MANAGEMENT ASSOCIATES INC
120 NORTH WASHINGTON ST SUITE 705	LANSING	MI	48933	LEGISLATIVE AND REGULATORY ANALYSIS	$205,000

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	11	CntrctRcvdGreaterThan100KCnt

Program Service Revenue ProgramServiceRevenueGrp (5 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt	Unrelated Business RevenueUnrelatedBusinessRevenueAmt
CONFERENCE/MTG REVENUE	541800	$53,479,396	$53,438,896	$40,500
MEMBERSHIP DUES	900003	$34,703,727	$34,703,727
SPECIAL INITIATIVES	900003	$2,020,623	$2,020,623
AG STATE LOBBYING FUND	900003	$1,002,397	$1,002,397
OTHER PROGRAM SERVICES	900003	$563,619	$563,619

Field	Value	IRS element (for citing)
Total Program Service Revenue	$91,769,762	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$4,550,666	TotalRevenueColumnAmt
Exclusion	$4,550,666	ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$16,603,683	TotalRevenueColumnAmt
Exclusion	$16,603,683	ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$101,192,827	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$96,368,230	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$4,824,597	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$4,824,597	TotalRevenueColumnAmt
Exclusion	$4,824,597	ExclusionAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$117,748,708	TotalRevenueColumnAmt
Related Or Exempt Func Income	$91,729,262	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$40,500	UnrelatedBusinessRevenueAmt
Exclusion	$25,978,946	ExclusionAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part IX	Yes (X)	InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$2,275,657	TotalAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$55,630	TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$5,683,009	TotalAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$264,130	TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$29,026,368	TotalAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$1,619,441	TotalAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$3,449,363	TotalAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$1,954,171	TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$1,171,505	TotalAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$98,136	TotalAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$4,858,828	TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$250,570	TotalAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$11,790,082	TotalAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$1,004,014	TotalAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$1,156,846	TotalAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$2,725,476	TotalAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$4,133,690	TotalAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$1,733,037	TotalAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$14,656,601	TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$6,296,126	TotalAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$914,712	TotalAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$441,682	TotalAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt
BANK FEES	$1,531,185
SUBSCRIPTIONS	$1,060,984
DUES & MEMBERSHIP	$1,039,043
TAXES PAID	$634,468

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$186,032	TotalAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$100,010,786	TotalAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$32,346,821	BOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
EOY	$35,818,032	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$5,320,200	BOYAmt
EOY	$5,248,657	EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

Field	Value	IRS element (for citing)
BOY	$78,566	BOYAmt
EOY	$0	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$4,097,309	BOYAmt
EOY	$5,517,200	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$19,580,091	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$3,651,802	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$12,905,261	BOYAmt
EOY	$15,928,289	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$80,707,801	BOYAmt
EOY	$85,815,523	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$21,183,389	BOYAmt
EOY	$21,761,393	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$156,639,347	BOYAmt
EOY	$170,089,094	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$12,067,134	BOYAmt
EOY	$11,349,725	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$21,531,353	BOYAmt
EOY	$19,408,585	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$45,680,833	BOYAmt
EOY	$46,159,983	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$79,279,320	BOYAmt
EOY	$76,918,293	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows FASB117	Yes (X)	OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$77,360,027	BOYAmt
EOY	$93,170,801	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$77,360,027	BOYAmt
EOY	$93,170,801	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$156,639,347	BOYAmt
EOY	$170,089,094	EOYAmt

Field	Value	IRS element (for citing)
Reconcilation Revenue Expnss	$17,737,922	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	-$1,927,148	NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets	$0	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	0	AccountantCompileOrReviewInd
FS Audited	Yes (1)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Separate Basis Fincl Stmt	Yes (X)	SeparateBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (1)	AuditCommitteeInd
Federal Grant Audit Required	0	FederalGrantAuditRequiredInd

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Political Expenditures	$460,000	PoliticalExpendituresAmt
Volunteer Hours	0	VolunteerHoursCnt
Expended527 Activities	$0	Expended527ActivitiesAmt
Internal Funds Contributed	$460,000	InternalFundsContributedAmt
Total Exempt Function Expend	$460,000	TotalExemptFunctionExpendAmt
Form1120 POL Filed	Yes (1)	Form1120POLFiledInd

Section527 Political Org Section527PoliticalOrgGrp (4 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Paid Internal FundsPaidInternalFundsAmt
DEMOCRATIC GOVERNORS ASSOCIATION
1225 EYE STREET NW SUITE 1100	WASHINGTON	DC	20005	521304889	$110,000
DEMOCRATIC LIEUTENANT GOVERNORS ASSOCIATION
1090 VERMONT AVE NW SUITE 750	WASHINGTON	DC	20005	030457299	$25,000
REPUBLICAN GOVERNORS ASSOCIATION
1747 PENNSYLVANIA AVENUE NW SUITE	WASHINGTON	DC	20006	113655877	$195,000
REPUBLICAN STATE LEADERSHIP COMMITTEE
1201 F STREET NW SUITE 675	WASHINGTON	DC	20004	050532524	$130,000

Field	Value	IRS element (for citing)
Substantially All Dues Nonded	0	SubstantiallyAllDuesNondedInd
Only In House Lobbying	0	OnlyInHouseLobbyingInd
Agree Carryover Prior Year	Yes (1)	AgreeCarryoverPriorYearInd
Dues Assessments	$34,054,440	DuesAssessmentsAmt
Non Deductible Lbbyng Pltcl CY	$9,587,874	NonDeductibleLbbyngPltclCYAmt
Non Ded Lbbyng Pltcl Cyov	-$4,847,908	NonDedLbbyngPltclCyovAmt
Non Deductible Lbbyng Pltcl Tot	$4,739,966	NonDeductibleLbbyngPltclTotAmt
Aggregate Reported Dues Ntc	$8,513,610	AggregateReportedDuesNtcAmt
Carried Over	-$3,773,644	CarriedOverAmt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I-A, LINE 1:	FormAndLineReferenceDesc
Explanation	BIO CONTRIBUTED FUNDS TO POLITICAL ACTION COMMITTEES IN 2024.	ExplanationTxt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$9,684,902	OtherCostOrOtherBasisAmt
Depreciation	$1,637,882	DepreciationAmt
Book Value	$8,047,020	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$2,741,518	OtherCostOrOtherBasisAmt
Depreciation	$679,067	DepreciationAmt
Book Value	$2,062,451	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$7,153,671	OtherCostOrOtherBasisAmt
Depreciation	$1,334,853	DepreciationAmt
Book Value	$5,818,818	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$15,928,289	TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp (2 entries)

DescDesc	Book ValueBookValueAmt
RIGHT OF USE ASSET - OPERATING	$20,635,867
DEFERRED COMPENSATION INVESTMENTS	$1,125,526

Field	Value	IRS element (for citing)
Total Book Value Other Assets	$21,761,393	TotalBookValueOtherAssetsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (8 entries)

DescDesc	AmtAmt
LEASE LIABILITY - OPERATING	$41,007,270
BIO-PAC	$155,327
DEFERRED COMPENSATION PLAN	$1,125,526
STATE AFFILIATE	$1,490,518
EVENT WITHHOLDING	$43,985
SPECIAL INITIATIVES	$2,187,606
UNAPPLIED RECEIPTS	$13,527
OTHER	$136,224

Field	Value	IRS element (for citing)
Total Liability	$46,159,983	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$115,632,753	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	-$1,927,148	NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts	$61,763	DonatedServicesAndUseFcltsAmt
Revenue Not Reported	-$1,865,385	RevenueNotReportedAmt
Revenue Subtotal	$117,498,138	RevenueSubtotalAmt
Investment Expenses Not Incld	$250,570	InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt	$250,570	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$117,748,708	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$99,821,979	TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts	$61,763	DonatedServicesUseFcltsAmt
Expenses Not Reported	$61,763	ExpensesNotReportedAmt
Expenses Subtotal	$99,760,216	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$250,570	InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt	$250,570	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$100,010,786	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART X, LINE 2:	FormAndLineReferenceDesc
Explanation	THE ORGANIZATION IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(6) OF THE INTERNAL REVENUE CODE (IRC) AS A SECTION 501(A) ORGANIZATION. HOWEVER, THE ORGANIZATION IS SUBJECT TO FEDERAL AND DISTRICT OF COLUMBIA TAXES ON ITS UNRELATED BUSINESS INCOME. THE ORGANIZATION'S TAX RETURNS ARE SUBJECT TO REVIEW AND EXAMINATION BY FEDERAL, STATE, AND LOCAL AUTHORITIES. THE ORGANIZATION HAS EVALUATED THEIR TAX POSITIONS AND DETERMINED THAT THEIR POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED ON EXAMINATION.	ExplanationTxt

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp

Field	Value	IRS element (for citing)
Region	EUROPE (INCLUDING ICELAND & GREENLAND)	RegionTxt
Type Of Activities Conducted	PROGRAM SERVICES	TypeOfActivitiesConductedTxt
Specific Services Provided	CONFERENCES, ADVOCACY AND EDUCATION	SpecificServicesProvidedTxt
Region Total Expenditures	$100,006	RegionTotalExpendituresAmt

Field	Value	IRS element (for citing)
Subtotal Offices	0	SubtotalOfficesCnt
Subtotal Employees	0	SubtotalEmployeesCnt
Continuation Total Office	0	ContinuationTotalOfficeCnt
Continuation Total Employee	0	ContinuationTotalEmployeeCnt
Total Office	0	TotalOfficeCnt
Total Employee	0	TotalEmployeeCnt
Subtotal Spent	$100,006	SubtotalSpentAmt
Continuation Spent	$0	ContinuationSpentAmt
Total Spent	$100,006	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (3 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt	Non Cash AssistanceNonCashAssistanceAmt	Description Of Non Cash AsstDescriptionOfNonCashAsstTxt	Valuation Method UsedValuationMethodUsedDesc
EUROPE (INCLUDING ICELAND & GREENLAND)	THIS IS FOR A SPONSORSHIP OF A BIOTECHBIKERS EVENT.	$7,000	WIRE TRANSFER	$0
EUROPE (INCLUDING ICELAND & GREENLAND)	COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO VENDOR	$0		$13,638	BIO ASSOCIATE MEMBERSHIP	FMV
CENTRAL AMERICA AND THE CARIBBEAN	TO SPONSOR THE PAVILION OF THE AMERICAS AGRI-FOOD SYSTEMS AT THE UN CLIMATE CONFERENCE	$25,000	ACH TRANSFER	$0

Field	Value	IRS element (for citing)
Total501c3 Org	0	Total501c3OrgCnt
Total Other Org	3	TotalOtherOrgCnt
Transfer To Foreign Corp	0	TransferToForeignCorpInd
Interest In Foreign Trust	0	InterestInForeignTrustInd
Foreign Corp Ownership	0	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	0	PassiveForeignInvestmestCoInd
Foreign Partnership	0	ForeignPartnershipInd
Boycott Countries	0	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART I, LINE 2:	THE ORGANIZATION PROVIDES NONCASH GRANTS IN THE FORM OF COMPLIMENTARY MEMBERSHIPS. ALSO PROVIDED ARE SPONSORSHIPS OF CONFERENCES AND EVENTS. THESE ARE BOTH EVALUATED EVERY YEAR.
PART I, LINE 3:	THE ORGANIZATION USES THE ACCRUAL METHOD OF ACCOUNTING TO REPORT EXPENDITURES FOR ACTIVITIES OUTSIDE THE U.S..

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (76 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	Cash GrantCashGrantAmt	Non Cash AssistanceNonCashAssistanceAmt	Valuation Method UsedValuationMethodUsedDesc	Non Cash AssistanceNonCashAssistanceDesc	Purpose Of GrantPurposeOfGrantTxt	IRC SectionIRCSectionDesc	Address Line2USAddress/AddressLine2Txt
ADP
99 JEFFERSON ROAD	PARSIPPANY	NJ	07054	221467904	$0	$32,272	FMV	BIO ASSOCIATE MEMBERSHIP	COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
AGRI-PULSE COMMUNICATIONS INC
110 WATERSIDE LANE	CAMDENTON	MO	65020	200696295	$13,500	$0			SPONSORSHIP
AIRGAS HEALTHCARE
259 N RADNOR CHESTER ROAD	RADNOR	PA	19087	560732648	$0	$32,272	FMV	BIO ASSOCIATE MEMBERSHIP	COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
ALLIANCE FOR AGING RESEARCH
1700 K STREET NW SUITE 740	WASHINGTON	DC	20006	541379174	$10,000	$0			SPONSORSHIP	501(C)(3)
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
655 15TH STREET NW SUITE 503	WASHINGTON	DC	20005	522340031	$27,500	$0			CONTRIBUTION	501(C)(4)
AMERICAN KIDNEY FUND INC
11921 ROCKVILLE PIKE SUITE 300	ROCKVILLE	MD	20852	237124261	$10,000	$0			SPONSORSHIP	501(C)(3)
AMERICAN LABORATORY TRADING (ALT)
12 COLTON RD	EAST LYME	CT	06333	874749183	$0	$32,272	FMV	BIO ASSOCIATE MEMBERSHIP	COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
AON RISK SOLUTIONS
1650 MARKET STREET SUITE 1000 ONE	PHILADELPHIA	PA	19103	521448077	$0	$32,272	FMV	BIO ASSOCIATE MEMBERSHIP	COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR		LIBERTY PLACE
ARIZONA BIOINDUSTRY ASSOCIATION INC
1800 E RAY RD SUITE A106	CHANDLER	AZ	85225	860938465	$12,000	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
AVANTOR
100 MATSONFORD ROAD RADNOR CORP	RADNOR	PA	19087	822758923	$0	$32,272	FMV	BIO ASSOCIATE MEMBERSHIP	COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR		CENTER BLDG 1 PO BOX 6660
BAY AREA BIOSCIENCE CENTER
685 GATEWAY BLVD SUITE 100	SOUTH SAN FRANCISCO	CA	94080	943118621	$10,000	$0			SPONSORSHIP	501(C)(3)
BAYH DOLE COALITION
1722A WISCONSIN AVE NW STE 21	WASHINGTON	DC	20007	881254803	$140,000	$0			CONTRIBUTION	501(C)(4)
BIO NEBRASKA LIFE SCIENCES ASSOCIATION
PO BOX 24802	OMAHA	NE	68124	202214508	$8,500	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
BIOCOM CALIFORNIA
10996 TORREYANA ROAD SUITE 200	SAN DIEGO	CA	92121	330496646	$5,000	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
BIOFLORIDA INC
6742 FOREST HILL BLVD 256	WEST PALM BEACH	FL	33413	593436638	$11,500	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
BIONJ INC
1255 WHITEHORSE MERCEVILLE ROAD STE	TRENTON	NJ	08619	223284393	$22,500	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	CONTRIBUTION AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)	514 BLDG B
BIOUTAH
PO BOX 58531	SALT LAKE CITY	UT	84158	900899204	$8,000	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	CONTRIBUTION AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
BREX
153 TOWNSEND STREET FLOOR 6	SAN FRANCISCO	CA	94107	364071727	$0	$32,272	FMV	BIO ASSOCIATE MEMBERSHIP	COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
CALIFORNIA LIFE SCIENCES ASSOCIATION
4242 CAMPUS POINT COURT SUITE 110	SAN DIEGO	CA	92121	473226523	$4,500	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
CENTER FOR FOOD INTEGRITY INC
2900 NE BROOKTREE LANE SUITE 200	GLADSTONE	MO	64119	204662713	$25,000	$0			CONTRIBUTION	501(C)(4)
CENTER FOR MEDICINE IN THE PUBLIC INTEREST
880 THIRD AVENUE 5TH FLOOR	NEW YORK	NY	10022	204321812	$10,000	$0			CONTRIBUTION	501(C)(3)
CHUBB
202 HALLS MILLS ROAD PO BOX 1650	WHITEHOUSE STATION	NJ	08889	132595722	$0	$32,272	FMV	BIO ASSOCIATE MEMBERSHIP	COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
CLEAN HARBORS
42 LONGWATER DRIVE	NORWELL	MA	02061	042698999	$0	$32,272	FMV	BIO ASSOCIATE MEMBERSHIP	COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
COLORADO BIOSCIENCE ASSOCIATION
600 GRANT STREET	DENVER	CO	80203	841363258	$5,000	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
COMMUNITY ACCESS NATIONAL NETWORK (CANN)
PO BOX 3009	SLIDELL	LA	70459	880370777	$10,000	$0			SPONSORSHIP	501(C)(3)
DAMON RUNYON CANCER RESEARCH FOUNDATION
ONE EXCHANGE PLAZA 55 BROADWAY	NEW YORK	NY	10006	131933825	$10,000	$0			SPONSORSHIP	501(C)(3)	SUITE 302
DELAWARE BIOSCIENCE ASSOCIATION INC
PO BOX 7708	WILMINGTON	DE	19803	204147195	$10,000	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	CONTRIBUTION AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
DEMOCRATIC GOVERNORS ASSOCIATION
1225 EYE STREET NW SUITE 1100	WASHINGTON	DC	20005	521304889	$110,000	$0			CONTRIBUTION	527
DEMOCRATIC LIEUTENANT GOVERNORS ASSOCIATION
1090 VERMONT AVE NW SUITE 750	WASHINGTON	DC	20005	030457299	$25,000	$0			CONTRIBUTION	527
EOSINOPHILIC & RARE DISEASE COOPERATIVE
8049 W BLACK EAGLE COURT	TUCSON	AZ	95757	862807827	$7,500	$0			CONTRIBUTION	501(C)(3)
EVERYLIFE FOUNDATION FOR RARE DISEASES
1012 14TH ST NW SUITE 500	WASHINGTON	DC	20005	237124261	$23,500	$0			CONTRIBUTION	501(C)(3)
GEORGIA BIOSCIENCES ORGANIZATION DBAGEORGIA LIFE SCIENCES COALITION
999 PEACHTREE STREET NE SUITE 1800	ATLANTA	GA	30309	273855537	$15,000	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
GOPAC EDUCATION FUND
1201 WILSON BLVD SUITE 2110	ARLINGTON	VA	22209	451475628	$25,000	$0			SPONSORSHIP	501(C)(4)
HEALTHCARE READY
1325 G STREET NW SUITE 500	WASHINGTON	DC	20005	463134601	$40,000	$0			CONTRIBUTION	501(C)(3)
HIV AND HEPATITIS POLICY INSTITUTE
1602B BELMONT STREET NW	WASHINGTON	DC	20009	844148678	$12,500	$0			CONTRIBUTION	501(C)(3)
HUMBOLDT STORAGE & MOVING
100 NEW BOSTON DRIVE	CANTON	MA	02021	041375440	$0	$32,272	FMV	BIO ASSOCIATE MEMBERSHIP	COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
IBIO (ILLINOIS BIOTECHNOLOGY INNOVATION ORGANIZATION)
400 N ABERDEEN ST SUITE 900	CHICAGO	IL	60642	364225980	$25,000	$0			SPONSORSHIP	501(C)(6)
INDIANA HEALTH INDUSTRY FORUM INC
429 E VERMONT STREET SUITE 304	INDIANAPOLIS	IN	46202	351955274	$4,000	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
INVEST IN MAINE'S FUTUREMAINE STATE CHAMBER OF COMMERCE
128 STATE ST SUITE 101	AUGUSTA	ME	04330	010021545	$10,000	$0			CONTRIBUTION	501(C)(6)
IOWA BIOTECHNOLOGY ASSOCIATION
500 E COURT AVE SUITE 112	DES MOINES	IA	50309	391885797	$5,000	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
LATINOS IN BIO INC
18 GROVE STREET SUITE 4	WELLESLEY	MA	02482	871185213	$10,000	$0			SPONSORSHIP	501(C)(3)
LIFE SCIENCE WASHINGTON
188 EAST BLAINE ST SUITE 150	SEATTLE	WA	98102	911453398	$7,500	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	CONTRIBUTION AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
LIFE SCIENCES PENNSYLVANIA
650 EAST SWEDESFORD RD SUITE 190	WAYNE	PA	19087	251621500	$23,100	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
LUPUS FOUNDATION OF AMERICA INC
2121 K STREET NW	WASHINGTON	DC	20037	431131436	$7,500	$0			CONTRIBUTION	501(C)(3)
MARYLAND TECHNOLOGY COUNCIL INC
12 W CHURCH ST SUITE 220	FREDERICK	MD	21701	204950778	$10,000	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
MASSACHUSETTS BIOTECHNOLOGY COUNCIL INC
700 TECHNOLOGY SQUARE FIFTH FLOOR	CAMBRIDGE	MA	02139	222693047	$7,500	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
MISSOURI BIOTECHNOLOGY ASSOCIATION
PO BOX 148	JEFFERSON CITY	MI	65102	431908699	$5,000	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
MONTANA BIOSCIENCE ALLIANCE
PO BOX 1773	BILLINGS	MT	59103	201647600	$14,500	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	CONTRIBUTION AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(3)
MUSCULAR DYSTROPHY ASSOCIATION INC
1016 W JACKSON BLVD 1073	CHICAGO	IL	60607	131665552	$7,500	$0			CONTRIBUTION	501(C)(3)
NATIONAL CONFERENCE OF STATE LEGISLATURES
PO BOX 17474	DENVER	CO	80217	840772595	$10,000	$0			CONTRIBUTION	170(C)(1)
NATIONAL GOVERNORS ASSOCIATION CENTER FOR BEST PRACTICES
444 N CAPITAL ST NW SUITE 267	WASHINGTON	DC	20001	237391796	$60,000	$0			CONTRIBUTION	501(C)(3)
NATIONAL HEALTH COUNCIL INC
1730 M STREET NW SUITE 500	WASHINGTON	DC	200364561	131624107	$75,000	$0			CONTRIBUTION	501(C)(3)
NATIONAL PSORIASIS FOUNDATION
6600 SW 92ND AVENUE	PORTLAND	OR	97223	930571472	$12,500	$0			SPONSORSHIP	501(C)(3)
NEWYORKBIO
25 HEALTH SCIENCES DR SUITE 203	STONY BROOK	NY	11790	113026494	$15,000	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
NIKON INSTRUMENTS
1300 WALT WHITMAN ROAD	MELVILLE	NY	11747	113554845	$0	$32,272	FMV	BIO ASSOCIATE MEMBERSHIP	COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
ODP BUSINESS SOLUTIONS
6600 NORTH MILITARY TRAIL SUITE 900	BOCA RATON	FL	33496	862161688	$0	$32,272	FMV	BIO ASSOCIATE MEMBERSHIP	COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
OHIO LIFE SCIENCES ASSOCIATION
1275 KINNEAR ROAD	COLUMBUS	OH	43212	920273822	$7,000	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
PREVENT CANCER FOUNDATION
333 JOHN CARLYLE STREET SUITE 635	ALEXANDRIA	VA	22314	521429544	$6,000	$0			SPONSORSHIP	501(C)(3)
PSC BIOTECH CORPORATION
700 CORPORATE CENTER DRIVE	POMONA	CA	91768	582239335	$0	$32,272	FMV	BIO ASSOCIATE MEMBERSHIP	COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
REPUBLICAN GOVERNORS ASSOCIATION
1747 PENNSYLVANIA AVENUE NW SUITE	WASHINGTON	DC	20006	113655877	$195,000	$0			CONTRIBUTION	527	250
REPUBLICAN STATE LEADERSHIP COMMITTEE
1201 F STREET NW SUITE 675	WASHINGTON	DC	20004	050532524	$130,000	$0			CONTRIBUTION	527
RESEARCHAMERICA
241 18TH STREET SOUTH SUITE 501	ARLINGTON	VA	22202	521609875	$40,000	$0			CONTRIBUTION	501(C)(3)
SC BIO
1140 WOODRUFF ROAD STE 106 BOX 121	GREENVILLE	SC	29607	823758723	$3,500	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
SHAREVAULT
16795 LARK AVENUE SUITE 210	LOS GATOS	CA	95032	562407915	$0	$32,272	FMV	BIO ASSOCIATE MEMBERSHIP	COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
TEXAS HEALTHCARE & BIOSCIENCE INSTITUTE
807 BRAZOS STREET SUITE 607	AUSTIN	TX	78701	760501034	$12,000	$2,827	FMV	BIO ASSOCIATE MEMBERSHIP	SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR	501(C)(6)
THE ARTHRITIS FOUNDATION INC
1355 PEACHTREE ST NE	ATLANTA	GA	30309	581341679	$10,000	$0			CONTRIBUTION	501(C)(3)
THE BRIGHAM AND WOMEN'S HOSPITAL INC
75 FRANCIS STREET	BOSTON	MA	02115	422312909	$10,000	$0			CONTRIBUTION	501(C)(3)
THE ECONOMIC CLUB OF WASHINGTON DC
1601 K STREET NW SUITE 210	WASHINGTON	DC	20006	521469926	$7,500	$0			SPONSORSHIP	501(C)(3)
THE GLOBAL WOMEN'S INNOVATION NETWORK (GLOBALWIN)
600 PENNSYLVANIA AVENUE SE UNIT 410	WASHINGTON	DC	20003	271428117	$25,000	$0			CONTRIBUTION	501(C)(3)
THE GOVERNING MAJORITY EDUCATION FUND
606 W WISCONSIN AVE STE 1202	MILWAUKEE	WI	53203	850549304	$25,000	$0			CONTRIBUTION	501(C)(4)
THE NATIONAL BLEEDING DISORDERS FOUNDATION
1230 AVENUE OF THE AMERICAS - 16TH	NEW YORK	NY	10020	135641857	$10,000	$0			CONTRIBUTION	501(C)(3)	FLOOR
UNIFIRST
68 JONSPIN ROAD	WILMINGTON	MA	01887	042103460	$0	$32,272	FMV	BIO ASSOCIATE MEMBERSHIP	COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
UPS
55 GLENLAKE PARKWAY NE	ATLANTA	GA	30328	582480149	$0	$32,272	FMV	BIO ASSOCIATE MEMBERSHIP	COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
US CHAMBER OF COMMERCE
1615 H STREET	WASHINGTON	DC	20062	530045720	$15,000	$0			CONTRIBUTION	501(C)(6)
WASHINGTON LEGAL FOUNDATION
2009 MASSACHUSETTS AVENUE NW	WASHINGTON	DC	20036	521071570	$20,000	$0			CONTRIBUTION	501(C)(3)
WOMEN IN BIO INC
PO BOX 97900	PITTSBURG	PA	15227	030458239	$15,000	$0			SPONSORSHIP	501(C)(3)

Field	Value	IRS element (for citing)
Total501c3 Org	27	Total501c3OrgCnt
Total Other Org	49	TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	BIO RELIES ON THE REQUIRED QUALIFICATIONS OF THE CONTRIBUTION AND SPONSORSHIP RECIPIENTS TO PROVIDE ASSURANCE OF PROPER USAGE. IN SOME CASES, BIO PERSONNEL ATTEND EVENTS AND RECEIVE ACKNOWLEDGMENTS RELATED TO THE FUNDS.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
First Class Or Charter Travel	Yes (X)	FirstClassOrCharterTravelInd
Written Policy Ref T And E Expnss	Yes (1)	WrittenPolicyRefTAndEExpnssInd
Substantiation Required	Yes (1)	SubstantiationRequiredInd
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	Yes (1)	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	Yes (1)	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	0	EquityBasedCompArrngmInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
JOHN F CROWLEY
PRESIDENT AND CEO	$2,224,033	$0	$500,000	$0	$23,000	$0	$365,352	$0	$0	$0	$3,112,385	$0	$0	$0
RACHEL K KING
INTERIM PRESIDENT AND CEO	$567,301	$0	$1,091,114	$0	$0	$0	$9,150	$0	$7,934	$0	$1,675,499	$0	$0	$0
ELIZABETH CARTIER ESHAM
CHIEF SCIENCE OFFICER	$431,800	$0	$198,432	$0	$382,166	$0	$8,103	$0	$10,825	$0	$1,031,326	$0	$0	$0
STEPHEN JASKO
CHIEF BUSINESS AND FINANCIAL OFFICER	$613,822	$0	$194,688	$0	$0	$0	$43,355	$0	$43,261	$0	$895,126	$0	$0	$0
PETER MCHUGH
CHIEF LEGAL OFFICER	$538,807	$0	$150,000	$0	$0	$0	$42,755	$0	$47,504	$0	$779,066	$0	$0	$0
RICHARD MASTERS
CHIEF PUBLIC AFFAIRS & MARKETING OFF	$266,716	$0	$175,950	$0	$302,044	$0	$6,516	$0	$19,852	$0	$771,078	$0	$0	$0
LETONIA D FYKES
CHIEF EVENTS & INDUSTRY PROGRAMS OFF	$443,332	$0	$152,755	$0	$0	$0	$43,355	$0	$29,641	$0	$669,083	$0	$0	$0
JOHN MURPHY
CHIEF POLICY OFFICER	$213,131	$0	$129,480	$0	$224,432	$0	$4,808	$0	$22,287	$0	$594,138	$0	$0	$0
MICHELLE MCMURRY-HEATH
FORMER PRESIDENT AND CEO	$0	$0	$0	$0	$264,130	$0	$0	$0	$0	$0	$264,130	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART I, LINE 1A	THE ORGANIZATION'S CEO WAS PERMITTED TO USE FIRST-CLASS FARES FOR BUSINESS TRAVEL PAID FOR BY THE ORGANIZATION. THE ORGANIZATION DID NOT TREAT FIRST-CLASS TRAVEL AS A TAXABLE FRINGE BENEFIT IN 2024.
PART I, LINE 1B	N/A FOR FIRST CLASS TRAVEL.
PART I, LINES 4A-B	NAME: MICHELLE MCMURRY-HEATH DESCRIPTION: SEVERANCE CURRENT YEAR AMOUNT: $264,130 PLAN DESCRIPTION: PAYMENTS MADE UPON SEPARATION OF SERVICE IN ACCORDANCE WITH AGREEMENT NAME: JOHN CROWLEY DESCRIPTION: 457(F) CONTRIBUTION WITH VESTING DATE OF DECEMBER 31, 2028 CURRENT YEAR AMOUNT: $331,148 PLAN DESCRIPTION: SECTION 457(F) DEFERRED COMPENSATION PLAN NAME: ELIZABETH CARTIER ESHAM DESCRIPTION: SEVERANCE CURRENT YEAR AMOUNT: $382,166 PLAN DESCRIPTION: PAYMENTS MADE UPON SEPARATION OF SERVICE IN ACCORDANCE WITH AGREEMENT NAME: RICHARD MASTERS DESCRIPTION: SEVERANCE CURRENT YEAR AMOUNT: $302,048 PLAN DESCRIPTION: PAYMENTS MADE UPON SEPARATION OF SERVICE IN ACCORDANCE WITH AGREEMENT NAME: JOHN MURPHY DESCRIPTION: SEVERANCE, CURRENT YEAR AMOUNT: $224,432 PLAN DESCRIPTION: PAYMENTS MADE UPON SEPARATION OF SERVICE IN ACCORDANCE WITH AGREEMENT

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp

Name Of Interested NameOfInterested

Field	Value	IRS element (for citing)
Person	SYLVIA WULF	PersonNm

Field	Value	IRS element (for citing)
Relationship Description	BIO DIRECTOR	RelationshipDescriptionTxt
Transaction	$195,849	TransactionAmt
Transaction	CONSULTING	TransactionDesc
Sharing Of Revenues	0	SharingOfRevenuesInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (8 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 1A	THE BOARD OF DIRECTORS SHALL DESIGNATE, BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN TWENTY-THREE (23) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE (EC). THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION; THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD (FB). IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FB, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FB SHALL BE SELECTED FOR THE EC. THE EC SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FB AS SET FORTH IN ARTICLE VI, SECTION 1(C) OF THE BYLAWS, EXCEPT THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION; TO CHANGE THE SIZE OF THE BOARD; AND TO ELECT OR REMOVE, OR MAKE DETERMINATIONS AS TO THE COMPENSATION OF THE DIRECTORS AND OFFICERS WHO ARE NOT EMPLOYEES OF THE ORGANIZATION.
FORM 990, PART VI, SECTION A, LINE 6	THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY FEWER THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS: ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS: ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION, OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER.
FORM 990, PART VI, SECTION A, LINE 7A	AT ALL MEMBERSHIP MEETINGS OF THE ORGANIZATION, EACH CURRENT MEMBER SHALL HAVE ONE (1) VOTE AND MAY TAKE PART IN THE VOTING IN PERSON OR BY PROXY. FOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION B, LINE 11B	THE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS WITH INFORMATION PROVIDED BY AND UNDER THE GUIDANCE OF THE CHIEF FINANCIAL OFFICER (CFO). THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CFO, AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. ALL REVIEWS ARE COMPLETED BEFORE THE FORM IS FILED WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12C	BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY KEY EMPLOYEES, OFFICERS AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIO'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIO'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT TO EACH DIRECTOR ON ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE.
FORM 990, PART VI, SECTION B, LINE 15	FOR 2024, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER (CEO) OF BIO (BIOTECHNOLOGY INNOVATION ORGANIZATION 52-1224577) WAS COMPENSATED PER THE TERMS OF A MULTI-YEAR CONTRACT THAT WAS DETERMINED WITH INDEPENDENT REVIEW, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION, AS INDICATED IN PRIOR FORM 990 SUBMISSIONS. IN ADDITION, BASED ON THE EXECUTIVE COMMITTEE'S EVALUATION OF THE PRESIDENT AND CEO'S PERFORMANCE FOR 2024, THE COMMITTEE DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF COMPENSATION FOR THAT YEAR, IN ACCORDANCE WITH THE RELEVANT PROVISION OF THE EXECUTIVE AGREEMENT. WHEN DETERMINING THE COMPENSATION OF THE BIO PRESIDENT & CEO, BIO HAS USED AN EXPERT OUTSIDE CONSULTANT TO BENCHMARK COMPENSATION. COMPENSATION OFTEN INCLUDES MORE THAN JUST SALARY AND BONUS, AND TO THIS END, BIO USES AN EXPERT OUTSIDE LEGAL COUNSEL WHO HAS EXTENSIVE EXPERIENCE IN NEGOTIATING THE TERMS OF CONTRACTS FOR THE PRESIDENT & CEO OF TRADE ASSOCIATIONS IN DC OF SIMILAR SIZE TO BIO. DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES. THE PROCESS DESCRIBED HERE WAS LAST COMPLETED IN 2024.
FORM 990, PART VI, SECTION C, LINE 19	THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC.
FORM 990, PART IX, LINE 11G	CONSULTANTS 8,363,663. EDUCATION & TRAINING 117,395. TEMPORARY STAFF 932,576. SPECIAL INITIATIVES 1,600,624. RECRUITING 775,824.